Aptinyx Inc reported $4.74M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Acorda Therapeutics ACOR:US $ 46M 8.02M
Biogen BIIB:US $ 3946.6M 351.6M
Cara Therapeutics CARA:US $ 18.3M 680K
Daiichi Sankyo 4568:JP Y 395268M 40073M
Eli Lilly And LLY:US $ 13386M 1666.7M
Halozyme Therapeutics HALO:US $ 111.69M 5.46M
Intra Cellular Therapies ITCI:US $ 59.07M 5.72M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Marinus Pharmaceuticals MRNS:US $ 19.54M 21.03M
Neurocrine Biosciences NBIX:US $ 253.5M 7.7M
Novartis NOVN:VX SF 29807M 401M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M
Vertex Pharmaceuticals VRTX:US $ 2180.2M 38.2M